Related Experiment Video
Updated: Aug 15, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Development of prostate cancer quality indicators: a modified Delphi approach
Anna R Gagliardi1, Neil Fleshner, Bernard Langer
1Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.
The Canadian Journal of Urology
|November 9, 2005
Summary
This study developed 11 quality indicators for prostate cancer care using a Delphi approach. These benchmarks help monitor and improve care quality, reducing patient harm and health system costs.
Area of Science:
- Urology
- Health Services Research
- Oncology
Background:
- Prostate cancer care exhibits significant variation in processes and outcomes.
- This variation can lead to patient harm and increased healthcare costs.
- Identifying measurable quality indicators is crucial for improving care.
Purpose of the Study:
- To develop evidence- and consensus-based quality indicators for prostate cancer care.
- To establish benchmarks for assessing and monitoring care quality.
- To identify measurable indicators correlating with improved patient outcomes.
Main Methods:
- A modified three-step Delphi approach was employed.
- A 17-member multidisciplinary panel reviewed and rated potential indicators.
- Expert consensus discussion and prioritization were used to finalize indicators.
Main Results:
- Eleven prioritized quality indicators for prostate cancer care were identified.
- These indicators cover diagnosis, surgery, pathology, and follow-up phases.
- Indicators span regional, hospital, and individual provider levels, including outcome measures.
Conclusions:
- A systematic approach yielded 11 key quality indicators for prostate cancer care.
- These indicators focus on pre-, peri-, and post-operative care, and outcomes.
- The indicators can guide quality monitoring and intervention development for providers and organizations.
